Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1
- 5 December 2003
- Vol. 22 (15-16) , 1946-1953
- https://doi.org/10.1016/j.vaccine.2003.11.011
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoidVaccine, 2001
- A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryVaccine, 2000
- Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine AntigensInfection and Immunity, 2000
- Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayersJournal of Controlled Release, 2000
- Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E‐negative calvesVeterinary Record, 1999
- Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheresVaccine, 1996
- Advances in the development and evaluation of bovine herpesvirus 1 vaccinesVeterinary Microbiology, 1996
- Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspectsVeterinary Record, 1996
- Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccineVaccine, 1994
- Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunitVaccine, 1988